Princeton Capital Management Inc’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Princeton Capital Management Inc's BMY Position: Q3 2017 in Review
Princeton Capital Management Inc increased its Bristol-Myers Squibb (BMY) stake by 18% in Q3 2017, buying an estimated $1.17M and bringing the position to 131,433 shares worth $8.38M. The position accounts for 4.24% of the portfolio, ranked #5.
Princeton Capital Management Inc first reported a position in BMY in Q2 2013 and has held it in 18 quarters since. 1,641 funds tracked by Wall St. Rank hold BMY as of Q3 2017.
- Princeton Capital Management Inc held 131,433 shares of Bristol-Myers Squibb worth $8.38M as of Q3 2017.
- Princeton Capital Management Inc bought 20,047 Bristol-Myers Squibb shares in Q3 2017, an estimated $1.17M.
- Bristol-Myers Squibb made up 4.24% of Princeton Capital Management Inc's portfolio in Q3 2017, its #5 holding.
- Princeton Capital Management Inc first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 18 quarters since.
- 1,641 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2017.
Based on Princeton Capital Management Inc's 13F filing for Q3 2017, filed 3 Nov 2017.